Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayDec 07, 2016 1:30 pm

Tonix Pharmaceuticals Holding (TNXP) Starts Presentation at LD Micro Main Event

Tonix Pharmaceuticals Holding (NASDAQ: TNXP) is a clinical-stage pharmaceutical company that develops medicines for common disorders of the central nervous system. The company's lead program focuses on post-traumatic stress disorder (PTSD) that is characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden. Its lead product candidate includes TNX-102 SL, a cyclobenzaprine HCl sublingual tablet; a phase III clinical stage for the treatment of PTSD; and phase II clinical stage for the treatment of military-related PTSD. For more information, visit the company's website at www.tonixpharma.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced…

Continue Reading

WednesdayDec 07, 2016 1:30 pm

22nd Century Group (XXII) Starts Presentation at LD Micro Main Event

22nd Century Group (NYSE: XXII) is a plant biotech company providing technology that allows for the level of nicotine and other nicotinic alkaloids in tobacco plants to be decreased or increased through genetic engineering and plant breeding. The company develops smoking cessation products and modified risk tobacco products for smokers who are unable or unwilling to quit smoking and who may be interested in cigarettes, which reduce exposure to nicotine or to certain tobacco smoke toxins and/or pose a lower health risk than conventional cigarettes. For more information, visit the company's website at www.xxiicentury.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news…

Continue Reading

WednesdayDec 07, 2016 1:30 pm

Heat Biologics (HTBX) Starts Presentation at LD Micro Main Event

Heat Biologics (NASDAQ: HTBX) is an immuno-oncology company developing novel therapies designed to activate a patient's immune system against cancer utilizing an engineered form of gp96, a protein that activates the immune system when cells die. Heat's highly specific T cell-stimulating therapeutic vaccine platform technologies, ImPACT and ComPACT, form the basis of its product candidates. Currently, Heat is conducting a phase 2 trial with its HS-410 in patients with non-muscle invasive bladder cancer (NMIBC) and a phase 1b trial with its HS-110 in combination with an anti-PD-1 checkpoint inhibitor to treat patients with non-small cell lung cancer (NSCLC). For more…

Continue Reading

WednesdayDec 07, 2016 1:30 pm

iPass (IPAS) Starts Presentation at LD Micro Main Event

iPass (NASDAQ: IPAS) provides global mobile connectivity, offering simple, secure, always-on Wi-Fi access on any mobile device. Built on a software-as-a-service (SaaS) platform, the iPass cloud-based service keeps its customers connected by providing unlimited Wi-Fi connectivity on unlimited devices. iPass is the world's largest Wi-Fi network, with more than 57 million hotspots in more than 120 countries, at airports, hotels, train stations, convention centers, outdoor venues, inflight, and more. Using patented technology, the iPass SmartConnect™ platform automatically connects customers to the best hotspot for their needs. For more information, visit the company's website at www.ipass.com. About NetworkNewsWire NetworkNewsWire (NNW) provides…

Continue Reading

WednesdayDec 07, 2016 1:30 pm

BioLineRx (BLRX) Starts Presentation at LD Micro Main Event

BioLineRx (NASDAQ: BLRX) a clinical-stage biopharmaceutical development company that engages in identifying, in-licensing and developing therapeutic candidates that address unmet medical needs. Its development pipeline consists of three primary clinical-stage therapeutic candidates: BL-8040, a novel peptide for the treatment of multiple cancer and hematological indications; BL-7010, a novel co-polymer for the treatment of celiac disease and gluten sensitivity; and BL-5010, a customized, proprietary, pen-like applicator containing a novel, acidic, aqueous solution as a medical device for the non-surgical removal of benign skin lesions. For more information, visit the company's website at www.biolinerx.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and…

Continue Reading

WednesdayDec 07, 2016 1:09 pm

FTE Networks, Inc. (FTNW) Appoints Industry Veterans as Initial Members of New Strategic Advisory Board

FTE Networks (OTCQX: FTNW) this morning said it has formed a strategic advisory board to provide senior counsel as it identifies and executes opportunities to advance the deployment of its disruptive multi-edge computing services. A leading network infrastructure company for Fortune 500 companies, FTE Network is filling this advisory board with a powerful caliber of experienced professionals. "The establishment of our Strategic Advisory Board represents our commitment to build on the company's recent momentum and pursue smart, strategic growth opportunities," Michael Palleschi, FTE Networks’ chairman of the board and CEO, stated in the news release. "Each member brings extensive cloud…

Continue Reading

WednesdayDec 07, 2016 1:00 pm

Bridgeline Digital (BLIN) Starts Presentation at LD Micro Main Event

Bridgeline Digital (NASDAQ: BLIN) is a digital company that helps customers maximize the performance of their full digital experience – from websites and intranets to online stores and campaigns. The company's iAPPS platform deeply integrates web content management, eCommerce, eMarketing, social media management, and Web Analytics to help marketers deliver digital experiences that attract, engage and convert their customers across all channels. For more information, visit the company's website at www.bridgelinedigital.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company…

Continue Reading

WednesdayDec 07, 2016 1:00 pm

Moleculin Biotech (MBRX) Starts Presentation at LD Micro Main Event

Moleculin Biotech (NASDAQ: MBRX) is a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on discoveries made at M.D. Anderson Cancer Center. The company's lead product candidate is Annamycin for the treatment of relapsed or refractory acute myeloid leukemia (AML). Moleculin Biotech also has two pre-clinical small molecule portfolios, one of which is focused on the modulation of hard-to-target tumor cell signaling mechanisms and the recruitment of the patient's own immune system. The other portfolio targets the metabolism of tumors. For more information, visit the company's website at www.moleculin.com. About…

Continue Reading

WednesdayDec 07, 2016 1:00 pm

MagneGas (MNGA) Starts Presentation at LD Micro Main Event

MagneGas (NASDAQ: MNGA) owns a patented process that converts various renewables and liquid wastes into MagneGas fuels for use as an alternative to natural gas or for metal cutting. The company's testing has shown that its metal cutting fuel "MagneGas2®" is faster, cleaner and more productive than other alternatives on the market. The company currently sells MagneGas2® into the metal working market as a replacement to acetylene. MagneGas also sells equipment for the sterilization of bio-contaminated liquid waste for various industrial and agricultural markets, and is developing a variety of ancillary uses for MagneGas® fuels utilizing its high flame temperature…

Continue Reading

WednesdayDec 07, 2016 1:00 pm

Coffee Holding Company (JVA) Starts Presentation at LD Micro Main Event

Coffee Holding Company (NASDAQ: JVA) manufactures, roasts, packages, markets and distributes roasted and blended coffees in the United States, Canada, Australia, England and China. The company offers wholesale green coffee products, which include unroasted raw beans of approximately 90 varieties that are sold to large, medium, and small roasters, as well as to coffee shop operators. It also roasts, blends, packages and sells coffee under private labels. For more information, visit the company's website at www.coffeeholding.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000